PL2732811T3 - Proces otrzymywania kompozycji liofilizowanej - Google Patents
Proces otrzymywania kompozycji liofilizowanejInfo
- Publication number
- PL2732811T3 PL2732811T3 PL12193209T PL12193209T PL2732811T3 PL 2732811 T3 PL2732811 T3 PL 2732811T3 PL 12193209 T PL12193209 T PL 12193209T PL 12193209 T PL12193209 T PL 12193209T PL 2732811 T3 PL2732811 T3 PL 2732811T3
- Authority
- PL
- Poland
- Prior art keywords
- freeze
- producing
- dried compound
- dried
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12193209.9A EP2732811B1 (de) | 2012-11-19 | 2012-11-19 | Verfahren zur Herstellung einer gefriergetrockneten Zusammensetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2732811T3 true PL2732811T3 (pl) | 2016-05-31 |
Family
ID=47191627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12193209T PL2732811T3 (pl) | 2012-11-19 | 2012-11-19 | Proces otrzymywania kompozycji liofilizowanej |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2732811B1 (pl) |
| DK (1) | DK2732811T3 (pl) |
| ES (1) | ES2564274T3 (pl) |
| HU (1) | HUE027287T2 (pl) |
| PL (1) | PL2732811T3 (pl) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4537883A (en) * | 1982-11-12 | 1985-08-27 | Mead Johnson & Company | Lyophilized cyclophosphamide |
| US8436190B2 (en) | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| EP2889029A1 (en) * | 2008-09-25 | 2015-07-01 | Cephalon, Inc. | Liquid formulations of bendamustine |
| WO2011103150A2 (en) | 2010-02-18 | 2011-08-25 | Cephalon, Inc. | Lyophilized preparations of bendamustine |
-
2012
- 2012-11-19 PL PL12193209T patent/PL2732811T3/pl unknown
- 2012-11-19 HU HUE12193209A patent/HUE027287T2/en unknown
- 2012-11-19 DK DK12193209.9T patent/DK2732811T3/en active
- 2012-11-19 ES ES12193209.9T patent/ES2564274T3/es active Active
- 2012-11-19 EP EP12193209.9A patent/EP2732811B1/de not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| DK2732811T3 (en) | 2016-03-21 |
| HUE027287T2 (en) | 2016-09-28 |
| EP2732811B1 (de) | 2016-01-13 |
| ES2564274T3 (es) | 2016-03-21 |
| EP2732811A1 (de) | 2014-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL263389B (en) | A method for the production of modified 5-fluoro-1h-pyrazolopyridines | |
| ZA201401133B (en) | Method for producing ternesite | |
| PL3632230T3 (pl) | Sposób składania do produkcji papierosów | |
| PL2826747T3 (pl) | Sposób wytwarzania difluorofosforanu | |
| SG11201404201XA (en) | Production method for polyamide | |
| IL237075A0 (en) | A method for the production of the hexahydropyropyranol derivative | |
| IL237052A0 (en) | A method for producing an oxazole compound | |
| EP2927207A4 (en) | PROCESS FOR PRODUCING CARBONYL COMPOUND | |
| SG11201501567QA (en) | Method for producing 7-octenal | |
| ZA201503525B (en) | Method for producing a brush and brush obtained by said method | |
| PL2925934T3 (pl) | Sposób wytwarzania pala | |
| IL241480B (en) | A method for the production of bacteriochlorophyll a | |
| IL231877A0 (en) | A method for the production of dithiene tetracarboximides | |
| EP2796464A4 (en) | PROCESS FOR THE PRODUCTION OF SYNTHETIC AMYLOSPHEROID | |
| SG11201504395SA (en) | Method for producing carbonate compound | |
| SG11201503452YA (en) | Method for producing polyamide | |
| PL2852513T3 (pl) | Sposób wytwarzania podzespołów | |
| GB201405815D0 (en) | A method for producing a biopolymer | |
| IL237885A (en) | Method for the production of isothiazole compound | |
| IL234526A (en) | METHOD FOR PRODUCING DIETHINE TETRACARBOXIMIDES | |
| IL231878A0 (en) | A method for the production of dithiene tetracarboximides | |
| EP2899292A4 (en) | PROCESS FOR PRODUCING A MACHINE PART | |
| EP2927206A4 (en) | PREPARATION FOR CARBONYL COMPOUND | |
| PL2732811T3 (pl) | Proces otrzymywania kompozycji liofilizowanej | |
| GB201216726D0 (en) | A method |